Newsroom
October 23, 2023
Shraddha Dalwadi, MD, Radiation Oncology, Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was interviewed for this news segment. Watch Now
October 9, 2023
Weixing Zhao, PhD, and Sandeep Burma, PhD, both with the Department of Biochemistry and Structural Biology and the UT Health San Antonio Mays Cancer Center, were quoted in this article. Read More
October 6, 2023
Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has pinpointed the molecular mechanism by which a large portion of these mutations cause cancers in women. The […]
September 28, 2023
Registration is open for the 46th annual San Antonio Breast Cancer Symposium, Dec. 5–9, at the Henry B. Gonzalez Convention Center. Experts will lead symposium discussions on clinical, translational and basic research. Attendees will receive information on experimental biology, etiology, prevention, diagnosis and therapy of breast cancer and premalignant breast disease. Click here to register.
September 1, 2023
The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) received a grant from the National Institutes of Health in excess of $590,000 that will be used to purchase a NanoWizard® 5 Atomic Force Microscope (NW5 AFM), the first of its class to be installed in San Antonio. […]
February 1, 2023
The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer. The U.S. Food and Drug Administration on Jan. 27 announced it approved the […]